Research outputs
2026
UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx)
Chauhan, D., Dello Russo, C., Thompson, J., Hughes, D. A., Payne, K., Tsakiroglou, M., . . . Pirmohamed, M. (2026). UGT1A1 genotype testing for irinotecan: A guideline developed by the UK Centre of Excellence in Regulatory Science and Innovation in Pharmacogenomics (CERSI-PGx). BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 92(9), 2986-3001. doi:10.1002/bcp.70659
Beyond data and technology: the need for new thinking to enable the era of precision prevention
Tsakiroglou, M., Harish, P., Hemingway, H., Blagden, S. P., Gardner, S., O'Connor, D., . . . Pirmohamed, M. (2026). Beyond data and technology: the need for new thinking to enable the era of precision prevention. BMC MEDICINE, 24(1), 10 pages. doi:10.1186/s12916-026-04938-1
2025
Data Visualisation of UKB HF Super-controls GWAS
Tsakiroglou, M., Elhariry, M., Zhang, E., & Pirmohamed, M. (2025). Data Visualisation of UKB HF Super-controls GWAS.
Pharmacogenomics in the UK National Health Service: Progress towards implementation
McDermott, J. H., Tsakiroglou, M., Newman, W. G., & Pirmohamed, M. (2025). Pharmacogenomics in the UK National Health Service: Progress towards implementation. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 91(8), 2241-2250. doi:10.1002/bcp.70109
2024
Gene Expression Dysregulation in Whole Blood of Patients with Clostridioides difficile Infection
Tsakiroglou, M., Evans, A., Doce-Carracedo, A., Little, M., Hornby, R., Roberts, P., . . . Pirmohamed, M. (2024). Gene Expression Dysregulation in Whole Blood of Patients with Clostridioides difficile Infection. International Journal of Molecular Sciences, 25(23), 12653. doi:10.3390/ijms252312653
2023
Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis
Tsakiroglou, M., Evans, A., & Pirmohamed, M. (2023). Leveraging transcriptomics for precision diagnosis: Lessons learned from cancer and sepsis. FRONTIERS IN GENETICS, 14, 17 pages. doi:10.3389/fgene.2023.1100352
Communication is crucial: Lessons from COVID-19 vaccination and pregnancy
Cole, C., Tsakiroglou, M., & Waitt, C. (2023). Communication is crucial: Lessons from COVID-19 vaccination and pregnancy. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 89(2), 582-593. doi:10.1111/bcp.15578
2022
Direct oral anticoagulants (DOAC), therapeutic drug monitoring and creatinine clearance
Bula, M., Simms, C., Ablett, C., Ahmed, M., Tempany, J., Tsakiroglou, M., & Pirmohamed, M. (2022). Direct oral anticoagulants (DOAC), therapeutic drug monitoring and creatinine clearance. In EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY Vol. 78 (pp. S145-S146). Retrieved from https://www.webofscience.com/
Opportunities for de-prescribing in a tertiary UK hospital
Cole, C., Pirmohamed, M., & Tsakiroglou, M. (2022). Opportunities for de-prescribing in a tertiary UK hospital. In EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY Vol. 78 (pp. S67). Retrieved from https://www.webofscience.com/
2020
HIV persistence during antiretroviral therapy: Characteristics of residual HIV-1 RNA in plasma
Tsakiroglou, M. (2020, August 23). HIV persistence during antiretroviral therapy: Characteristics of residual HIV-1 RNA in plasma.
2014
The influence of gender on ART-induced reconstitution of CD4 cell counts and function
Tsakiroglou, M., Wang, Y., Ruggiero, A., King, S., Beloukas, A., & Geretti, A. (2014). The influence of gender on ART-induced reconstitution of CD4 cell counts and function. HIV MEDICINE, 15, 48. Retrieved from https://www.webofscience.com/
HIV: new drugs, new guidelines
Geretti, A. M., & Tsakiroglou, M. (2014). HIV: new drugs, new guidelines. CURRENT OPINION IN INFECTIOUS DISEASES, 27(6), 545-553. doi:10.1097/QCO.0000000000000106
2011
Women's knowledge and utilization of gynecological cancer prevention services in the Northwest of Greece.
Tsakiroglou, M., Bakalis, M., Valasoulis, G., Paschopoulos, M., Koliopoulos, G., & Paraskevaidis, E. (2011). Women's knowledge and utilization of gynecological cancer prevention services in the Northwest of Greece.. European journal of gynaecological oncology, 32(2), 178-181.